» Articles » PMID: 15743534

New York City HIV Superbug: Fear or Fear Not?

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2005 Mar 4
PMID 15743534
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

On February 11, 2005, the New York City Department of Health and Mental Hygiene announced that a city resident had recently been infected with a multi-drug resistant form of HIV and rapidly progressed to AIDS. The Health Commissioner, Thomas R. Frieden, called for increased vigilance against this new strain. Is this situation an emerging crisis or simply an unusual case report of rapid HIV progression?

Citing Articles

Yeast for virus research.

Zhao R Microb Cell. 2017; 4(10):311-330.

PMID: 29082230 PMC: 5657823. DOI: 10.15698/mic2017.10.592.


Evaluation of the impact of news coverage of an HIV multiclass drug-resistant cluster in Seattle, Washington.

Kahle E, Barash E, Page L, Lansky A, Jafa K, Sullivan P Am J Public Health. 2009; 99 Suppl 1:S131-6.

PMID: 19218180 PMC: 2724959. DOI: 10.2105/AJPH.2007.126656.

References
1.
Paltiel A, Weinstein M, Kimmel A, Seage 3rd G, Losina E, Zhang H . Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med. 2005; 352(6):586-95. DOI: 10.1056/NEJMsa042088. View

2.
Philpott S . HIV-1 coreceptor usage, transmission, and disease progression. Curr HIV Res. 2004; 1(2):217-27. DOI: 10.2174/1570162033485357. View

3.
Sheppard H, Celum C, Michael N, OBrien S, Dean M, Carrington M . HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr. 2002; 29(3):307-13. DOI: 10.1097/00126334-200203010-00013. View

4.
Sanders G, Bayoumi A, Sundaram V, Bilir S, Neukermans C, Rydzak C . Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005; 352(6):570-85. DOI: 10.1056/NEJMsa042657. View

5.
Bozzette S . Routine screening for HIV infection--timely and cost-effective. N Engl J Med. 2005; 352(6):620-1. DOI: 10.1056/NEJMe048347. View